Company Quick10K Filing
Medicine Man Technologies
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$0.00 32 $36
10-Q 2019-11-12 Quarter: 2019-09-30
10-Q 2019-08-14 Quarter: 2019-06-30
10-Q 2019-05-20 Quarter: 2019-03-31
10-K 2019-04-16 Annual: 2018-12-31
10-Q 2018-11-08 Quarter: 2018-09-30
10-Q 2018-08-08 Quarter: 2018-06-30
10-Q 2018-05-03 Quarter: 2018-03-31
10-K 2018-03-27 Annual: 2017-12-31
10-Q 2017-11-09 Quarter: 2017-09-30
10-Q 2017-08-17 Quarter: 2017-06-30
10-Q 2017-05-16 Quarter: 2017-03-31
10-Q 2017-05-16 Quarter: 2017-03-31
10-K 2017-04-17 Annual: 2016-12-31
10-Q 2016-11-14 Quarter: 2016-09-30
10-Q 2016-08-15 Quarter: 2016-06-30
10-Q 2016-05-16 Quarter: 2016-03-31
10-K 2016-04-14 Annual: 2015-12-31
10-Q 2015-11-12 Quarter: 2015-09-30
8-K 2020-02-25 Officers, Exhibits
8-K 2020-02-24 Regulation FD, Exhibits
8-K 2020-02-24 Regulation FD, Exhibits
8-K 2020-02-20 Regulation FD, Exhibits
8-K 2019-12-10 Amend Bylaw, Shareholder Vote, Exhibits
8-K 2019-12-09 Officers, Amend Bylaw, Exhibits
8-K 2019-11-23 Enter Agreement, Regulation FD, Exhibits
8-K 2019-11-11 Earnings, Exhibits
8-K 2019-10-21 Amend Bylaw, Exhibits
8-K 2019-09-16 Regulation FD
8-K 2019-09-09 Enter Agreement, Exhibits
8-K 2019-09-09 Other Events, Exhibits
8-K 2019-09-06 Enter Agreement, Exhibits
8-K 2019-09-02 Enter Agreement, Exhibits
8-K 2019-08-31 Enter Agreement
8-K 2019-08-30 Enter Agreement, Exhibits
8-K 2019-08-29 Enter Agreement, Exhibits
8-K 2019-08-28 Enter Agreement, Exhibits
8-K 2019-08-15 Enter Agreement, Exhibits
8-K 2019-08-14 Earnings, Exhibits
8-K 2019-08-06 Enter Agreement, Exhibits
8-K 2019-07-15 Enter Agreement, Sale of Shares, Other Events, Exhibits
8-K 2019-06-06 Enter Agreement, Exhibits
8-K 2019-06-05 Enter Agreement, Sale of Shares, Officers, Amend Bylaw, Other Events, Exhibits
8-K 2019-05-24 Enter Agreement
8-K 2019-05-15 Officers
8-K 2019-04-26 Officers
8-K 2019-03-14 Officers
8-K 2019-02-28 Regulation FD, Other Events, Exhibits
8-K 2019-01-10 Enter Agreement, Regulation FD, Exhibits
8-K 2018-12-03 Officers, Regulation FD, Exhibits
8-K 2018-12-01 Officers
8-K 2018-09-17 Enter Agreement, Regulation FD, Exhibits
8-K 2018-07-17 Enter Agreement, Exhibits
8-K 2018-06-25 Officers, Shareholder Vote, Exhibits

Medicine Man Technologies Financials

MDCL Metrics, Comps, Filings

Annual | Quarterly

Business

Medicine Man Technologies, Inc. (“we,” “us,” “our” or the “Company”) was incorporated on March 20, 2014, in the State of Nevada. On May 1, 2014, we entered into a non-exclusive Technology License Agreement with Futurevision, Inc., fka Medicine Man Production Corp., dba Medicine Man Denver (hereinafter, “Medicine Man Denver”) pursuant to which Medicine Man Denver granted us a license to use all of their proprietary processes that they had developed, implemented and practiced at their cannabis facilities relating to the commercial growth, cultivation, marketing and distribution of medical marijuana and recreational marijuana pursuant to relevant state laws and the right to use and to license such information, including trade secrets, skills and experience (present and future) (the “License Agreement”) in consideration for the issuance of 5,331,000 shares of our Common Stock. We accounted for this license in accordance with ASC 350-30-30 “Intangibles - Goodwill and Other” by recognizing the fair value of the amount paid by us for the asset at the time of purchase. Since we had a limited operating history, management elected to use the par value of our Common Stock as the value recognized for the transaction. Since the term of the License Agreement is ten (10) years, the cost of the asset will be recognized on a straight-line basis over the life of the License Agreement. In addition, we will evaluate the intangible asset for impairment every quarter. Medicine Man Denver is owned by some of our affiliates. See “Part II, Item 8, Financial Statements and Supplementary Data” and “Part III, Item 13, Certain Relationships and Related Transactions.”

Acquisition of Pono Publications, Ltd., Success Nutrients, Inc. and Associated Intellectual Property

On February 27, 2017, we entered into a Merger Agreement with Pono Publications Ltd., as well as a Share Exchange Agreement with Success Nutrients, Inc., each a Colorado corporation, in order to facilitate our acquisition of both of these entities, which were owned by Joshua_Haupt, who currently serves as one of our directors.


Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Stockholders' Equity

Income Statement ($MM Annual)

Revenue, Gross Profit, Net Income

Cash Flow ($MM Annual)

Operating, Investing, Financing

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
Leafbuyer (LBUY) 36,895 109% -5.1 -175% 3,915 3,279 1,892 2,064 -6,835 -7,160 36,713
Xplore Technologies (XPLR) 36,845 30% 14.6 0% 63,578 33,303 86,852 25,892 300 2,519 36,799
Cannabis Sativa (CBDS) 36,574 52% -16.5 -59% 4,489 2,699 454 238 -2,665 -2,219 36,514
Exeo Entertainment (EXEO) 36,179 39% -32.7 -146% 761 1,762 127 49 -1,113 -1,104 36,043
Exactus (EXDI) 35,907 26% -8.0 -81% 6,426 2,224 156 40 -5,221 -4,410 35,343
Darkpulse (KLMK) 35,876 -25.8 -397% 584 3,359 0 0 -2,320 -1,432 36,998
Equitable Financial (EQFN) 35,831 -0.0 0% 305,668 269,015 0 0 571 3,492 -156
FoodFirst (BBRG) 35,805 0% 31.4 -11% 133,876 166,149 398,247 0 -15,391 2,421 76,068
BLOX (BLXX) 35,706 -3.1 -932% 1,250 622 0 0 -11,649 -11,649 35,697
Western Capital Resources (WCRS) 35,677 56% -0.9 1% 89,005 23,300 114,140 64,322 1,043 4,438 -4,095
Innovation Pharmaceuticals (IPIX) 35,645 -4.5 -205% 4,046 8,175 0 0 -8,282 -7,859 35,066
Medicine Man Technologies (MDCL) 35,582 57% -2.9 -51% 21,365 7,738 10,550 6,041 -10,993 -10,916 31,234
Uwharrie Capital (UWHR) 35,197 -8.6 1% 627,363 579,310 0 0 3,417 7,901 -67,687
PASSUR Aerospace (PSSR) 35,194 44% 6.0 -25% 14,769 13,759 15,175 6,661 -3,756 5,859 35,190
American International Holdings (AMIH) 34,681 58% -332.1 -23% 472 904 91 53 -106 -104 34,703
NightFood (NGTF) 34,438 56% -8.6 -870% 460 2,043 431 241 -4,002 -4,002 34,400
VIST Financial (VIST) 34,227 5.7 -1% 1,409,982 1,294,454 0 0 -20,376 2,172 12,476
Onelife Technologies (OLMM) 34,215 -108.4 -144% 320 2,813 0 0 -462 -316 34,258
Zivo Bioscience (ZIVO) 34,165 -2.7 -11,417% 112 11,271 0 0 -12,813 -12,813 34,122
Atlantic Alliance Partnership (AAPC) 33,577 69,949.5 37% 1 265 0 0 0 0 33,576

Balance Sheet ($'000)2015-12-312016-12-312017-12-312018-12-31
Cash262352749322
Accounts Receivable84254611,181
Inventory106489
PP&E484215095
Assets47772811,13218,222
Accounts Payable90123203
Long-Term Debt
Liabilities221,1043931,148
Stockholders' Equity455-37610,73917,074
Income Statement ($'000)2015-12-312016-12-312017-12-312018-12-31
Revenue8366313,5309,443
Cost of Revenue2104621,0342,578
Gross Profit6261692,2276,865
R&D
SG&A4406941,553744
Tax0120583
Net Income86-1,464-5,381949
Cash Flow ($'000)2015-12-312016-12-312017-12-312018-12-31
Cash Operating302-741-6741,287
Cash Investing-10421-34-150
Cash Financing108101,1051,000